All mutations in the coding sequences of TP53 that were identified in our sample of patients with DLBCL had been described earlier in the IARC TP53 mutations database [11] in other oncological diseases, and these mutations (with the exception of р.A307A) are located in exons 5–8 coding for the DNA-binding domain p53. This evidence concerns the gene TP53 and diffuse large B-cell lymphoma.